Impact of lockdown on cardiovascular disease hospitalizations in a Zero-COVID-19 country.

Authors:
Moury PH; Ochida N; Motiejunaite J; Collart V; Série M and 6 more

Journal:
Public Health

Publication Year: 2023

DOI:
10.1016/j.puhe.2023.01.029

PMCID:
PMC9894760

PMID:
36867989

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Public Health

Abbreviation: Public Health

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Public Health

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Analysis of primary care electronic health record data of people living with hepatitis B virus: inf…
Campbell C; Wang T; Gillespie I and 2 more (2023) - Transparency Score: 4/6
An intra-action review conducted by the CDC Foundation during COVID-19 to evaluate emergency respon…
Bednar H; McMillan S; Seidl M and 2 more (2023) - Transparency Score: 3/6
Assessing the construction of a Healthy City in China: a conceptual framework and evaluation index …
Zhao M; Qin W; Zhang S and 3 more (2023) - Transparency Score: 3/6
COVID-19 vaccine hesitancy in a developing country: prevalence, explanatory factors and implication…
Wynter-Adams D; Thomas-Brown P. (2023) - Transparency Score: 3/6
COVID-19 vaccines effectiveness against symptomatic disease and severe outcomes, 2021-2022: a test-…
Brazete C; Brazete J; Alves F and 7 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests A.M. received honorarium for lectures from Novartis, Roche, Abbott, Orion, Servier, consultation fees from Corteria and Windtree, and research grant from 4TEEN4, Adrenomed, Roche, Abbott. Disclosure None."

Evidence found in paper:

"Funding This study was supported by institutional funding."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025